Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Urani

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Headache and Pain|June 13, 2026
Consistency of response to rimegepant for the acute treatment of migraine among real-world users - findings from the prospective observational CONFIDENCE studyRichard B Lipton, Lucy Abraham, Alexandre Urani, et al.
Medical Hypotheses|June 19, 2007
CREB-regulated diurnal activity patterns are not indicative for depression-like symptoms in mice and menSabine Chourbaji, Christiane Brandwein, Daniel Gau, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 29, 2006
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophreniaPhilippe Pichat, Olivier E Bergis, Jean-Paul Terranova, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Headache and Pain|June 13, 2026
Consistency of response to rimegepant for the acute treatment of migraine among real-world users - findings from the prospective observational CONFIDENCE studyRichard B Lipton, Lucy Abraham, Alexandre Urani, et al.
Medical Hypotheses|June 19, 2007
CREB-regulated diurnal activity patterns are not indicative for depression-like symptoms in mice and menSabine Chourbaji, Christiane Brandwein, Daniel Gau, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 29, 2006
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophreniaPhilippe Pichat, Olivier E Bergis, Jean-Paul Terranova, et al.
Pageof 3